Encephalitis (Apr 2023)

Myelin oligodendrocyte glycoprotein antibody-associated encephalitis after severe acute respiratory syndrome coronavirus 2 infection: a case report and retrospective case reviews

  • Yoonkyung Lee,
  • Seon-Jae Ahn,
  • Han-Sang Lee,
  • Yongmoo Kim,
  • Seolah Lee,
  • Hyeyoung Park,
  • Jangsup Moon,
  • Sang Kun Lee,
  • Kon Chu

DOI
https://doi.org/10.47936/encephalitis.2022.00129
Journal volume & issue
Vol. 3, no. 2
pp. 71 – 77

Abstract

Read online

Several cases of myelin oligodendrocyte glycoprotein (MOG) antibody-associated encephalitis have been reported after coronavirus disease 2019 (COVID-19). In this case, the patient presented with focal status epilepticus with impaired awareness, auditory hallucinations, and incoherent speech after COVID-19. Brain magnetic resonance imaging revealed no specific findings. Cerebrospinal fluid results showed pleocytosis and MOG antibody testing confirmed anti-MOG antibody with live cell-based fluorescence-activated cell sorting assay. The patient was diagnosed with MOG antibody-associated autoimmune encephalitis and treated with intravenous immunoglobulin, rituximab, and tocilizumab. This case occurred presumably due to auto-antibody production following COVID-19.

Keywords